Page 3 - Ablation System News Today

AtriCure, Inc. , a leading innovator in surgical treatments and therapies for atrial fibrillation , left atrial appendage management, and post-operative pain management, today announced that it will...

The REBALANCE-HF trial at HFSA 2023 reveals that right greater splanchnic nerve ablation was well-tolerated and safe in patients with HFpEF, with additional analysis shedding light on the proportion of responders to the procedure.

Minerva Surgical, Inc. (NASDAQ:UTRS – Get Free Report)’s stock price hit a new 52-week low on Monday . The company traded as low as $2.77 and last traded at $2.89, with a volume of 10521 shares traded. The stock had previously closed at $3.29. Minerva Surgical Stock Performance The stock has a market cap of […]

Minerva Surgical, Inc. (NASDAQ:UTRS – Free Report)’s stock is going to reverse split on Monday, October 2nd. The 1-20 reverse split was announced on Monday, October 2nd. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, October 2nd. Minerva Surgical Stock Performance Minerva Surgical stock remained flat at […]

Minerva Surgical, Inc. (NASDAQ:UTRS – Free Report) shares are set to reverse split before the market opens on Monday, October 2nd. The 1-20 reverse split was announced on Monday, October 2nd. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, October 2nd. Minerva Surgical Price Performance NASDAQ UTRS […]

Shares of Minerva Surgical, Inc. (NASDAQ:UTRS – Get Free Report) were down 5.2% during trading on Wednesday . The company traded as low as $0.20 and last traded at $0.20. Approximately 105,795 shares traded hands during trading, a decline of 95% from the average daily volume of 2,118,215 shares. The stock had previously closed at […]

/PRNewswire/ -- On August 29, 2023, Broncus Medical (02216.HK), a leader in precise interventional diagnosis and therapy of lung diseases in China, announced...

Minerva Surgical (NASDAQ:UTRS – Get Free Report) and West Pharmaceutical Services (NYSE:WST – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings. Insider and Institutional Ownership 89.6% of Minerva […]

Minerva Surgical, Inc. (NASDAQ:UTRS – Get Free Report)’s share price dropped 2.1% during mid-day trading on Tuesday . The company traded as low as $0.22 and last traded at $0.23. Approximately 172,008 shares traded hands during mid-day trading, a decline of 92% from the average daily volume of 2,291,629 shares. The stock had previously closed […]

Nephros (NASDAQ:NEPH – Get Free Report) and Minerva Surgical (NASDAQ:UTRS – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, dividends, risk, earnings and valuation. Volatility & Risk Nephros has a beta of […]